Stock-Based Compensation - Narrative (Details) (USD $)	12 Months Ended			12 Months Ended	3 Months Ended		1 Months Ended			1 Months Ended	3 Months Ended				1 Months Ended	12 Months Ended		1 Months Ended		3 Months Ended		12 Months Ended		12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013	Dec. 31, 2013 Vertro	Mar. 31, 2013 2005 LTIP and 2010 ECP Plan	Dec. 31, 2012 2005 LTIP	Feb. 29, 2012 Employee Compensation Plan 2010	Jan. 31, 2012 Employee Compensation Plan 2010	Dec. 31, 2012 Employee Compensation Plan 2010	Jul. 31, 2012 Restricted stock units	Dec. 31, 2013 Restricted stock units	Jun. 30, 2013 Restricted stock units	Mar. 31, 2013 Restricted stock units	Dec. 31, 2012 Restricted stock units	Jul. 31, 2012 Restricted stock units Executive Officers, Senior Management and Board of Directors	Dec. 31, 2013 Restricted Stock	Dec. 31, 2012 Restricted Stock	Jul. 31, 2012 Restricted Stock Management	Jul. 31, 2012 Restricted Stock Non-management	Sep. 30, 2013 Restricted Stock Units- Service Based	Sep. 30, 2013 Restricted Stock Units- Performance Based	Dec. 31, 2013 Options	Dec. 31, 2012 Options	Dec. 31, 2013 Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Option and restricted stock unit vesting period											3 years		3 years											3 years
Compensation Expense
Stock based compensation	$ 686,745	$ 842,752			$ 49,577
Compensation cost related to non vested awards not yet recognized	701,164
Average remaining expense recognition period	1 year 3 months 18 days
Significant Grants and Cancellations
Equity instruments other than options, grants in period (in shares)										445,500	428,500	80,000	100,000		296,505	1,116,000		148,995	49,500	172,500	335,000
Weighted average grant date price			$ 0.87								$ 1.31			$ 0.70
Shares settled																252,755
Shares issued																173,371
Options cancelled					805,134
Number of additional shares authorized (in shares)							2,500,000.0	100,357
Number of shares authorized (in shares)	4,535,945					1,000,000.0			3,385,945
Equity instruments other than options, nonvested, weighted average grant date fair value (usd per share)																$ 1.45	$ 0.71		$ 0.56
Grants in period, weighted average grant date fair value											$ 1.44	$ 0.77	$ 0.72			$ 1.07
Award Information and Activity
Expected forfeiture rate																						4.60%
Aggregate intrinsic value of outstanding options	0			0
Weighted average remaining contractual term	6 years 10 months 15 days			1 year 1 month 1 day
Number of options exercisable (in shares)	266,408
Intrinsic value of options exercisable	0
Weighted average exercise price	$ 2.72
Weighted average remaining contractual term	6 years 11 months 15 days
Fair value of options vested	240,000	609,000
Intrinsic value of options exercised	2,813
Options forfeited and expired in period	882,703			5,504
Forfeited or expired, weighted average exercise price	$ 2.65			$ 22.64
Options outstanding	292,746	1,179,199		165,827
Options, weighted average exercise price	$ 2.72	$ 2.66		$ 45.36																		$ 18.14	$ 2.56
Weighted average fair value of options				$ 0
Range of exercise price, lower Llmit (usd per share)	$ 12.55
Range of exercise price, upper limit (usd per share)	$ 74.84
Granted in period	0	49,500
Forfeited in period																0